InvestorsHub Logo

Clonefan

04/26/17 10:52 AM

#20801 RE: Darkoo #20799

And don't forget Keough is also an expert in losing Millions in market cap for that failed merger.

Mistral

04/26/17 10:57 AM

#20803 RE: Darkoo #20799

I wouldn't bank on Otiko's version of facts. He is obviously weak on IP/Patent law and FDA rules. The FDA still reflects ViaDerma II as the registrant of Viabecline. Their business license has been revoked by Nevada.

He absolutely sucks at full disclosure.

Otiko formed ViaDerma and promoted Keough's IP in 2014--long before the USPTO Transaction History indicated negative actions (that can be reversed). The last abandonment notice was in 2015. One of the published applications indicates an Information Disclosure Statement is being considered.

THERE IS NO FINAL ACTION ON THE PUBLISHED PATENT-PENDING APPLICATIONS.

There are contracts in the case docket that tell a story.

An expert at letting patents expire and making all the IP public record..